Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol

Dow Jones

May 02

By Christopher Kuo

Shares of Eton Pharmaceuticals climbed to a fresh high after the company relaunched Hemangeol, its treatment for a type of infantile birthmark known as hemangioma.

The biopharmaceutical company's stock rose 18%, to $28.48, midday Friday after hitting a record high of $29.80 earlier in the session. The shares are up 68% so far this year.

Hemangeol, an oral solution approved by the Food and Drug Administration, is available exclusively through Anovo Specialty Pharmacy, Eton said. The company launched the drug with a patient support service known as Eton Cares.

The prescription drug treats infantile humangiomas, which are non-cancerous tumors that typically appear in the first days or weeks of a baby's life, the company said.

Write to Christopher Kuo at chris.kuo@wsj.com

(END) Dow Jones Newswires

May 01, 2026 15:00 ET (19:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2632448236"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2632448236\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2632448236?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-02 03:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632448236","market":"us","top_or_hot":-1,"title":"Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Christopher Kuo \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Eton Pharmaceuticals climbed to a fresh high after the company relaunched Hemangeol, its treatment for a type of infantile birthmark known as hemangioma. \n</p>\n<p>\n  The biopharmaceutical company's stock rose 18%, to $28.48, midday Friday after hitting a record high of $29.80 earlier in the session. The shares are up 68% so far this year. \n</p>\n<p>\n  Hemangeol, an oral solution approved by the Food and Drug Administration, is available exclusively through Anovo Specialty Pharmacy, Eton said. The company launched the drug with a patient support service known as Eton Cares. \n</p>\n<p>\n  The prescription drug treats infantile humangiomas, which are non-cancerous tumors that typically appear in the first days or weeks of a baby's life, the company said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Christopher Kuo at chris.kuo@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 01, 2026 15:00 ET (19:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-02 03:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Christopher Kuo \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Eton Pharmaceuticals climbed to a fresh high after the company relaunched Hemangeol, its treatment for a type of infantile birthmark known as hemangioma. \n</p>\n<p>\n  The biopharmaceutical company's stock rose 18%, to $28.48, midday Friday after hitting a record high of $29.80 earlier in the session. The shares are up 68% so far this year. \n</p>\n<p>\n  Hemangeol, an oral solution approved by the Food and Drug Administration, is available exclusively through Anovo Specialty Pharmacy, Eton said. The company launched the drug with a patient support service known as Eton Cares. \n</p>\n<p>\n  The prescription drug treats infantile humangiomas, which are non-cancerous tumors that typically appear in the first days or weeks of a baby's life, the company said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Christopher Kuo at chris.kuo@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 01, 2026 15:00 ET (19:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ETON","symbol_name":"Eton Pharmaceuticals, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2632448236","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632448236","pubTimestamp":1777662000,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Eton Pharmaceuticals climbed to a fresh high after the company relaunched Hemangeol, its treatment for a type of infantile birthmark known as hemangioma.The biopharmaceutical company's stock rose 18%, to $28.48, midday Friday after hitting a record high of $29.80 earlier in the session. The shares are up 68% so far this year.Hemangeol, an oral solution approved by the Food and Drug Administration, is available exclusively through Anovo Specialty Pharmacy, Eton said. The company launched the drug with a patient support service known as Eton Cares.The prescription drug treats infantile humangiomas, which are non-cancerous tumors that typically appear in the first days or weeks of a baby's life, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ETON":"Eton Pharmaceuticals, Inc.","BK4007":"制药"},"translate_title":"伊顿制药(Eton Pharmaceuticals)因重新推出Hemangeol而创下新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ETON":0.9},"content_text":"By Christopher Kuo \n\n\n \n\n\n  Shares of Eton Pharmaceuticals climbed to a fresh high after the company relaunched Hemangeol, its treatment for a type of infantile birthmark known as hemangioma. \n\n\n  The biopharmaceutical company's stock rose 18%, to $28.48, midday Friday after hitting a record high of $29.80 earlier in the session. The shares are up 68% so far this year. \n\n\n  Hemangeol, an oral solution approved by the Food and Drug Administration, is available exclusively through Anovo Specialty Pharmacy, Eton said. The company launched the drug with a patient support service known as Eton Cares. \n\n\n  The prescription drug treats infantile humangiomas, which are non-cancerous tumors that typically appear in the first days or weeks of a baby's life, the company said. \n\n\n \n\n\n  Write to Christopher Kuo at chris.kuo@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 01, 2026 15:00 ET (19:00 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}